Tag: Cambrex

Cambrex expands its North American facility

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic APIs, announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa plant

Cambrex and AstraZeneca entered a long-term manufacturing agreement

Cambrex Corporation held an opening ceremony with AstraZeneca at its Karlskoga, Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies

Cambrex finished the expansion of API manufacturing facility in Sweden

Cambrex Corporation announced that it has completed the installation of new, large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden

Cambrex expanded its US facility with a $3.2 million analytical lab

Cambrex Corporation announced that it is expanding its High Point, North Carolina, facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory